Soon after the introduction of the one-and twostage methods for determining prothrombin, it was noted that while the results obtained by the two procedures generally agreed fairly well, marked discrepancies occurred in certain specific instances. Particularly puzzling has been the observation that the prothrombic activity of human blood as compared with dog blood, when measured by the two tests, is markedly different. Warner, Brinkhous and Smith (1) reported that the prothrombin concentration in dog blood is 350 units per cc. and in human blood 295 units. More recently Murphy and Seegers (2) found 190 to 205 units in dog and 290 to 315 in human blood. Mann and his associates (3, 4) reported that the average for dog blood is 183 units per cc. and for human blood 319 units. These findings indicate that the prothrombin concentration as measured by the two-stage method is approximately the same in the two species. When determined by the one-stage method, the prothrombic activity of dog blood, in marked contrast, is many-fold higher than in human blood (5) . The reason for this divergency has not been satisfactorily explained, but obviously as long as this problem remains unsolved, a marked gap in the knowledge concerning prothrombin remains. In the present investigation human and dog bloods were studied by means of the prothrombin consumption test and by the adsorption and elution technique for determining prothrombin with the aim of obtaining new data that might be helpful in arriving at a better understanding of what constitutes prothrombic activity.
METHODS
The prothrombin consumption time. The directions as previously outlined were followed (6, 7) . In carrying out the prothrombin consumption test on serum from platelet-poor plasma, blood is collected with a siliconecoated needle and syringe, and immediately transferred to silicone-coated test tubes immersed in an ice bath. After the tubes are chilled for 10 minutes, they are centrifuged in an Angle Centrifuge at 8000 r.p.m. for 10 minutes. One cc. of the plasma (having a platelet count less than 3000 per mm.) is transferred to a glass test tube and placed in a water bath at 370 C. The fibrin is removed as it forms by wrapping it about a glass stirring rod. When the coagulation of fibrinogen is complete, the serum is tested every five minutes for its prothrombic activity. Usually it becomes constant in 15 minutes. The prothrombin time is determined as follows: To a mixture consisting of 0.1 cc. deprothrombinized oxalated rabbit plasma, 0.1 cc. thromboplastin and 0.1 cc. 0.02 M CaCl2 solution, 0.1 cc. of serum is added by blowing from a pipette. The formation of the clot is accurately timed.
The determination of prothrombin by the adsorption and elution technique as developed by Stefanini and the writer (8) was followed. In this test the prothrombin is adsorbed with tricalcium phosphate and then eluted with sodium citrate. Since one volume of eluate contains the prothrombin of 10 volumes of plasma, the eluate is mixed with nine volumes of deprothrombinized rabbit plasma for assaying its prothrombic activity. Rabbit plasma has been found to be a satisfactory assay medium because it has a high and constant concentration of labile factor.
RESULTS
A comparative study of the prothrombic activity of human and dog plasmas and sera are recorded in Table I . The prothrombin time of normal human plasma is 12 seconds and of dog plasma six seconds. The same values are obtained when determined by the adsorption and elution procedure. On storing oxalated human and dog plasma in an open container at 40 C., the prothrombin time steadily increases but in human plasma the rise is much more rapid. If deprothrombinized rabbit plasma, which is a rich source of labile factor, is added to the stored human plasma, the prothrombin time is decreased to eight seconds. Likewise, the eluate obtained from aged human plasma yields a prothrombin time of eight seconds. When the labile factor is restored in 903 Although it has been shown that increasing the labile factor above the minimum level required for optimum prothrombin time does not further shorten it (9) , it may still be claimed that the higher concentration of labile factor in dog blood might be responsible for the faster clotting time. When the prothrombin is determined by the adsorption and elution procedure, the labile factor is not a variable, because in the assay of the eluate, a standard amount of deprothrombinized rabbit plasma, which has a high concentration of labile factor, is employed. The close agreement between the results of the direct one-stage and the adsorption and elution method is good evidence that the labile factor does not influence the results of the one-stage method unless it is below the minimal requirement.
When normal dog blood clots, the prothrombin time of the serum increases because most of the prothrombin is converted to thrombin. In the experiment recorded in Table I , Exp. 5, the prothrombin time of the serum is 15 seconds. By means of the prothrombin curve for dog blood obtained by saline as a diluent (7), one can estimate that over 90 per cent of the prothrombin in this serum is consumed. In marked contrast, when platelet-poor plasma clots, the prothrombin time of the serum is practically the same as that of the plasma (Table I, Exp. 6). On account of the lack of platelets, so little thromboplastin apparently becomes available that only a very small amount of prothrombin is consumed. It is to be noted that in serum from both platelet-rich and poor plasma the prothrombin time by the direct one-stage method agrees with the values obtained by the adsorption and elution test. When oxalated dog plasma is stored, the prothrombin time slowly increases, but the eluate from this aged plasma had a prothrombin time of six to six and one-half seconds ( it becomes necessary to postulate that an accelera- [2 12 [8 8 tor is generated to account for the decrease of the prothrombin time from the normal of 12 seconds to 8 eight seconds. Alexander and his associates (12) 8-9 8-9 have attempted to establish that such a specific 8 8 agent exists. They have named it spca (serum prothrombin converting accelerator) because they maintain that the prothrombic activity of serum t likewise has is due largely to the evolution of this factor durven when the ing clotting. If their contentions are correct, then Exps. 4 and the marked increase of prothrombic activity found d hemophilic in the serum from hemophilic or from thromboea prothrom-cytopenic blood should be due to spca, but acnds. Thus, a cording to their findings this factor is low in these in prothrom-sera (13, 14) . From this it would follow that the t-free normal marked hyperprothrombic activity in these sera asmas and in is not due to the evolution of an accelerator but
In none of to an actual increase in prothrombin. a very small According to Alexander, spca, like prothrombin, d; therefore, is adsorbed by BaSO4 and eluted with sodium ci-;. This, how-trate. In isolating spca, they allow blood to clot ig increase in and treat the serum with BaSO4 (20 mgm. per 1 cc. rect and sim-serum). From their statement (15) : "most of the crease in pro-prothrombic activity was in the supernatant" after pen one may adsorption with BaSO4, one must infer that these inactive or investigators assume that differential adsorption Bordet (10) occurs in which spca is separated from prothromprothrombin bin. On repeating their procedure, it has been in an inactive found that as much as two-thirds of the prothrom-)ncluded that bic activity of serum is removed by 20 mgm. of nbin is active, BaSO4 per 1 cc. (16). There is therefore a strong the precursor probability that the separation of spca and proke active pro-thrombin is more apparent than real and that the I eluted. The product considered to be the accelerator contains rise increases an undetermined amount of prothrombin. Alexresumably be-ander and Landwehr's (17) finding that the evoluianged to ac-tion of spca during storage is small in various hyound that the poprothrombic states might well be explained by for maximum a low concentration of prothrombin in the accelerprothrombin ator preparation. To determine how much of the *othrombin is activity is due to prothrombin and how much to ritamin K de-an accelerator becomes not only a formidable but lent decreases. a speculative problem.
needed to obThus, while the possibility of an accelerator me of stored factor should not be ignored, it seems simpler and perhaps more firmly supported by experimental evidence that the hyperprothrombic activity in the conditions discussed is due to an actual increase in active prothrombin. The statement of Stefanini and Crosby (18) that the prothrombin time of serum is not influenced by the activation of the precursor of prothrombin in less than two hours after the completion of clotting is not in accord with the findings of the writers. In the clotting of native human plasma the prothrombin time of the serum attains a constant value in about 15 minutes after all the fibrinogen has been converted to fibrin. In oxalated plasma, the conversion of inactive prothrombin to the active state is slow. At 40 C. the reaction usually requires more than 24 hours to go to completion, even in contact with a glass surface, and in a silicone-coated container it even takes considerably longer. This permits the removal of both prothrombin and prothrombinogen from oxalated plasma by adsorption with tricalcium phosphate, and the subsequent recovery of both forms by elution with sodium citrate.
The finding that neither storage nor the clotting of platelet-poor dog plasma causes an increase of prothrombic activity such as is observed in human plasma, makes it unlikely that dog blood contains a prothrombin converting factor of the type of spca. One is at a loss, therefore, to find a better explanation for the high prothrombic activity of dog blood than that it contains a much higher concentration of active prothrombin than does human blood, but has little or no inactive prothrombin.
SUM MARY
The comparative prothrombic activity of dog and human blood were studied by means of the one-stage prothrombin test, the prothrombin consumption test and the adsorption and elution technique for determining prothrombin.
It was found that the prothrombic activity of dog blood is much greater than that of human blood. When oxalated dog plasma is stored, the prothrombin time is increased due to loss of labile factor. When the latter is restored, the prothrombin time returns to the value obtained for fresh plasma. The serum from platelet-poor normal plasma has a prothrombin time only slightly less than that of plasma.
Human plasma on storage likewise shows a progressive decrease of prothrombic activity but when the labile factor is restored, the prothrombin time becomes shorter than that of the fresh plasma. A similar increase in prothrombic activity is found when normal platelet-poor plasma, or hemophilic plasma clots.
Possible explanations for these findings are discussed. It is concluded that dog blood contains a high concentrate of free or active prothrombin but little or no inactive prothrombin, whereas human plasma has a much smaller amount of free prothrombin, but a high concentration of inactive prothrombin (prothrombinogen), which in contact with a glass surface becomes converted to the active state.
